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Abstract: Magnetic nanoparticles (MNPs) are key elements in several biomedical
applications, e.g., in cancer therapy. Here, the MNPs are remotely manipulated by
magnetic fields from outside the body to deliver drugs or generate heat in tumor tissue.
The efficiency and success of these approaches strongly depend on the spatial distri-
bution and quantity of MNPs inside a body and interactions of the particles with the
biological matrix. These include dynamic processes of the MNPs in the organism such
as binding kinetics, cellular uptake, passage through cell barriers, heat induction and
flow. While magnetic measurement methods have been applied so far to resolve the
location and quantity of MNPs for therapymonitoring, thesemethods can be advanced
to additionally access these particle–matrix interactions. By this, the MNPs can further
be utilized as probes for the physical properties of their molecular environment. In this
review,we first investigate the impact of nanoparticle–matrix interactions onmagnetic
measurements in selected experiments. With these results, we then advanced the
imaging modalities magnetorelaxometry imaging and magnetic microsphere tracking
to spatially resolve particle–matrix interactions.
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1 Magnetic measurement methods to support
biomedical applications of magnetic nanoparticles
Magnetic nanoparticles (MNPs) used in biomedical applications typically consist of a
magnetic iron oxide (e.g., magnetite, maghemite) core of 4–30 nm in diameter sur-
rounded by an organic shell. Their uniquemagnetic properties and the small size of the
MNPs allow them to function at a cellular level, making them attractive candidates for
cell labeling, imaging, tracking and as carriers. MNPs serve as actuators and local
probes in novel therapeutic and diagnostic applications (for review see e.g., [1–4]). For
instance, inmagnetic hyperthermia an alternatingmagnetic field is applied toward the
MNPs for local heating of tumor tissue. In magnetic drug targeting, the MNPs serve as
drug carriers that are remotely guided toward a tumor by magnetic field gradients to
accumulate the drug on the tumor side. Other examples are targeted accumulation of
geneticmaterial (magnetofection) and contrast agents formagnetic resonance imaging
and magnetic particle imaging (MPI).
In all these applications, the MNPs get into contact and thus interact with a bio-
logical environment or the surrounding physiological matrix such as tissue, cells, or
the bloodstream. The safety and success of these applications vitally depends on a
quantitative and spatially resolved knowledge of the interactions attributed to the
biological environment. This can be accomplished by probing the surrounding matrix
via magnetic measurement techniques capable of tracking changes in the magnetic
behavior of MNPs. Examples are the investigation of cellular MNPuptake in target cells
[5–7], MNP triggered cell growth [8, 9], the long-term fate andmetabolism ofMNPs [10],
MNP-matrix interactions affecting hyperthermia application [11, 12], the interaction of
MNPs with blood molecules [13, 14], biological matrices [15] and the passage of MNPs
through cell barriers [16–19].
One possibility to analyze particle–matrix interactions (PMIs) is by probing the
dynamics of theMNPmagneticmoments. The ensemblemagnetization respondswith a
time delay to a change in an external magnetic field. For immobilized MNPs, this delay
is determined by the Néel relaxation time [20] necessary for the magnetic moments to
overcome the energy barriers resulting from magneto-crystalline structure and/or
shape anisotropy. If the MNPs are embedded in a matrix but are still free to mechan-
ically rotate as a whole, Brownian relaxation [21] is possible. The Brownian relaxation
time depends on the viscosity of the matrix and the hydrodynamic MNP size distri-
bution. If both relaxation mechanisms are present, the faster mechanism dominates
the resulting effective MNP relaxation.
In the following, we describe somemagnetic measurements probing the rotational
MNPmotion to investigate PMIs for biomedical applications. In Section 2, we introduce
the magnetic measurement techniques used to characterize MNP–matrix systems.
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These are applied in Section 3 on well-defined MNP-matrix systems to investigate the
effect of PMIs in the respectiveMNP response. In Sections 4 and 5, we incorporate these
results into the development of novel imaging modalities for a quantitative and
spatially resolved description of PMIs.
2 Magnetic measurement and imaging techniques
2.1 Magnetorelaxometry
In magnetorelaxometry (MRX) [22], the MNP response to a fast change in an applied
magnetic field is detected by a sensitive magnetic field sensor, e.g., a Superconducting
Quantum Interference Device (SQUID) [22] or a fluxgate [23]. MRX measurements
consist of two consecutive phases. In a first magnetizing phase, a static magnetic field
Hvwith a typical amplitude of 1 mT/µ0 is applied toward the MNP sample at position rv
in order to partially align the individual particle moments along the field direction
resulting in a net magnetic moment m0 = χm  HvXMNP. This moment depends on the
mass susceptibilityχm (m
3/kg) of the MNPs, the strength of the applied magnetic field
Hv and the MNP mass XMNP within the sample. In the subsequent measurement phase
initiated by switching off the applied magnetic field, the decay of this net magnetic
moment over time is detected. This decay is determined by Néel [20] and Brownian
relaxation [21] processes and can be described as m( t) = m0 ⋅ κ( t) where the mono-
tonically decreasing relaxation function κ( t) displays values between one and zero.
Both relaxation mechanisms are characterized by a specific time constant:




The Brownian relaxation time τB is determined by the hydrodynamic volume Vh of the
nanoparticle, the local viscosity η of the particle surroundings, and its thermal agita-
tion given by temperature T and Boltzmann constant kB. The Néel relaxation time is
defined by a time constant τ0 with values in literature between 10−8 and 10−12 s [24], the
anisotropy constant K and the volume of its magnetic core Vc. If both relaxation
mechanisms occur, the particle relaxation is determined by an effective relaxation time
τeff
τeff(Vc,Vh) = τN(Vc)τB(Vh)τN(Vc) + τB(Vh) (2)
in which the fastest relaxation mechanism dominates the effective relaxation time. In
practice, MNP systems exhibit a broad size distribution P(Vc,Vh). Hence, the relaxation
function κ( t) detected in MRX experiments is composed of effective relaxation times
given by both the core and hydrodynamic MNP size distribution.
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In theMRXmeasurement phase, the decaying net magnetic momentm(t) of a MNP
source at position rv gives rise to the MRX signal Bs( t) in sensor s. The measured flux
density of a point-like MNP source, Bs( t) detected by sensor s at position rs with a
sensitive axis ns = [nx, ny, nz] (normal vector of the sensor) is given by [25]:
Bs(t) = μ04π (
3(nTs(rs − rv))(rs − rv)T)
‖(rs − rv)‖5 −
nTs
‖(rs − rv)‖3)Hv  χm  κ(t)XMNP (3)
where µ0 is the vacuum permeability and Hv is the magnetic field on position rv. The
obtainedMRX curve can be parametrized by the relaxation amplitude ΔB (=B(t1) − B(t2)
with t1 < t2) and the relaxation time t1/e, i.e. the period after that κ( t) has dropped by
36.7% of its value at B(t1). The relaxation amplitude is directly proportional to the MNP
amount of the sample allowing for MNP quantification. The relaxation time parameter
t1/e depends on the Brownian and Néel relaxation processes which will be employed to
probe interactions between the nanoparticles and the physiological samples
environment.
2.2 Magnetorelaxometry imaging
Magnetorelaxometry imaging (MRXI) is a sensitive and specific imaging modality for
3D quantification of MNP distributions. In MRXI, the MRX response of a MNP sample is
measured on different locations by a sensor array [26, 27], where the spatial encoding is
improved by applying a series of spatially constrained magnetic fields using a number
of K excitation coils surrounding the measurement volume [25, 28, 29]. By combining
all individual MRX measurements, the quantitative 3D reconstruction of the MNP
distribution can be obtained as a solution of an inverse problem.
In classical MRX imaging, the presence of only one type of MNPs in the mea-
surement volume is assumed, corresponding to one relaxation function κ(t). Note that
the only time dependency in the model of Equation (3) relies in κ(t). It becomes static
when only the difference in amplitude κ(t1, t2) = κ(t1) − κ(t2) with t1 < t2 is of interest.
Thus, the classical MRXI forward model calculates only the difference in amplitude
between two time points, t1 and t2, of theMRX signalBs(t1, t2). In practice, the relaxation
product χm κ(t1, t2) is obtained from an MRX measurement of a reference sample con-
taining a known MNP amount.
Equation (3) can be simplified by including previous MNP material and geometry
parameters of the MRXI setup in the sensitivity coefficient Lsv linking the particle mass
in voxel v to the measurement in sensor s
Bs(t1, t2) = Lsv  XMNP, v (4)
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Equation (4) can be extended from just one sensor and one voxel to S sensors and V
voxels:
B = [B1,…,BS]T = ∑
V
v=1
Ls, v  XMNP, v = LXMNP (5)
with the sensitivity matrix L having dimensions (S × V) and XMNP being a vector
containing the MNP masses for each voxel v [XMNP,1,…, XMNP,V]
T. In practice, the MRX
measurements (Equation 5) are performed for K spatially varying magnetic fields
generated by the excitation coils. This results in the following forward model
Bsim = [B1,…,BK]T = [L1,…, LK]T  XMNP (6)
with Bk containing the S relaxation measurements for the k-th magnetic field pattern
and Lk the corresponding sensitivity matrix. In our MRXI setup 30 excitation coils are
applied sequentially to magnetize the MNP distribution with 30 spatially distinct
magnetic fields. Thus, we obtain K = 30 × S single MRXmeasurements and a sensitivity
matrix L of dimension (KS ×V). TheMNPdistribution consisting ofVMNPmassesXMNP
is then recovered by solving
X∗MNP = argminXMNP ‖ Bsim − Bmeas‖ (7)
where the difference between the modeled measurements Bsim, and the actual MRX
measurements Bmeas, are minimized by searching for the most probable MNP distri-
butionXMNP to causeBmeas. Equation (7) has been successfully solved in previous work
using a non-negative least squares (NNLS) [30] and by truncated singular value
decomposition (tSVD) [26, 29]. In NNLS, Equation (7) is iteratively solved with the
constraints that all elements of the solution (i.e. the MNP amounts) are positive [31]
w = LT(Bsim − Bmeas) (8)
In this equation,w is the dual vector and should finally only contain elements smaller
than or equal to zero, so that the solution X∗MNPonly has positive elements.
2.3 MNP response to alternating magnetic fields
In contrast to the static magnetic field applied in MRXmagnetization, PMIs can also be
characterized by the MNP response to alternating magnetic fields. For moderate field
amplitudes (0.5–1 mT/µ0) this is referred to as AC susceptibility (ACS). ACS uses an
induction coil system to measure the linear dynamic magnetic response of a sample to
an alternating magnetic field within the frequency range 10 Hz–0.5 MHz. At these
moderate magnetic field amplitudes, ACS data is well described by the Debye model
[32], where
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χ′(ω) = χ0




1 + (ωτeff)2 (10)
are the real χ′(ω) and imaginary parts χ″(ω) of the complex susceptibility χ(ω). The





with µp the moment of a single particle and np the number of particles. The phase φ of
the complex susceptibility is defined by φ = arctan(χ″(ω)/χ′(ω)). Note that the
effective relaxation time τeff is determined as the maximum in the imaginary part
ωτeff = 1. Similar to MRXI, additional spatial encoding in ACS by multiple sensors or
excitation coils allows for the development of MNP imaging approaches [33–36].
Increasing the amplitude of the AC magnetic field allows to obtain additional signal
contributions of the MNPs by their nonlinear magnetic susceptibility. This is employed in
Magnetic Particle Spectroscopy (MPS). Here, the MNP response to AC magnetic fields of
some tens ofmT/µ0 (hereB= 25mT) atfixed frequency in the kHz range (here f0 = 25 kHz) is
detected by an induction coil system. The MPS signal does not only contain signal com-
ponents at the excitation frequency f0, but also MNP-specific higher harmonics (i.e. odd
multiples of f0). After obtaining the MPS spectrum from a Fourier transformation, two
characteristic parameters can be extracted. These are the amplitude of the third harmonic
M3 and theharmonic ratioM5/M3, i.e. amplitude ratio betweenfifth and thirdharmonic.M3
is directly proportional to theMNP amount of the sample.M5/M3 depends on the dynamic
magnetic behavior of the MNPs and is often used as indicator for PMIs [12]. In magnetic
particle imaging (MPI) [37], this concept is combined with a spatial encoding by magnetic
gradient fields for the 3D quantitative imaging of MNP distributions.
3 Interaction of MNPs with matrices
Nanoparticle matrix systems generally consist of MNPs embedded in a nonmagnetic
often soft material environment. Prominent technical applications are MNP-polymer
systems where mechanical properties of the matrix like the elastic moduli shall be
controlled by external magnetic fields (e.g., [38–40]). In a biological MNP-matrix
system the MNP can be located in the cellular system (inside the cell, at the cell surface
or in the intercellular space) and may be targeted to transport a drug by external
magnetic fields. Since the magnetic response of the MNPs is sensitive to the particle
surrounding, this offers a way to analyze PMIs. To reduce the complexity of biological
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systems, one often resorts to model systems like MNPs embedded in hydrogel (also
called ferrogel). Here, the viscous hydrogel emulates the biological matrix with well-
defined properties. Microscopically, the hydrogel is not a homogeneous matrix, but a
polymer scaffold filled with an aqueous, solvating fluid.
The PMIs in hydrogels are mainly caused by (i) the MNP binding with the polymer
scaffold and (ii) the drag of MNP movements determined by the (local) viscosity of the
solvating fluid and the inner structure of the hydrogel, e.g., the pore size and its
connectivity. On the other hand, the coating and the hydrodynamic size of the MNPs
are important factors to study PMIs. For instance, the presence of functional groups like
carboxylate groups (COO−) in the coatingmay lead to a preferential binding of MNPs to
positively charged domains of the hydrogel scaffold. The drag of the MNP motion is
caused by the fluid resistance, which ismainly determined by the hydrodynamic size of
the MNPs but also by reversible (weak) bonding caused by macromolecular entan-
glement between coating molecules and matrix molecules. The binding functionality
can be measured using a magnetic assay [41], but in the following we focus on the
physical structure of the coating, i.e. its thickness and density.
Asmagneticmeasurement techniqueswe applyMRX, ACS andMPS (Section 2) and
analyze PMIs by detecting changes in the Brownian and Néel relaxation of the MNPs.
We used MNP systems with different core material and coating. For convenience they
are labeled Xi*Y, where the first letter X indicates the core material, with X = M for
magnetite and X = C for cobalt ferrite, followed by a consecutive sample number i. The
term Y after the delimiting * denotes the key molecular part of the coating. Here,
Y=COO− indicates carboxylate groups, Y=CONH-PEG denotes amino-PEG (poly-
ethylene-glycol) coupled to a carboxylate group and, Y=S stands for silica (SiO2).
3.1 Probing the melting of a matrix by Brownian MNP relaxation
First, we investigated the melting behavior of ferrogels in gelatin. Here, we used the
Brownian relaxation of the MNPs to probe the local viscosity of the matrix during its
melting. To this end we used MPS and MRX as sensitive magnetic measurement
techniques to detect variations in the MNP relaxation caused by matrix property
changes during the melting (e.g., disintegration, reduced viscosity).
Figure 1 displays the MRX relaxation time and the MPS amplitude of the third
harmonic normalized to iron mass M3 during the melting process of gelatin, i.e. as a
function of temperature. As expected, significant parameter changes are observed for
temperature close to the gelatin melting point of about 308 K. This is attributed to the
onset of Brownian rotation of the MNPs becoming possible above the melting point.
Interestingly, there are small parameter changes already before the macroscopic
melting point (Figure 1). These are interpreted as local melting [42], where the MNPs
sense amaceration of the matrix without being disintegrated. This is further confirmed
by a drop in the MRX relaxation amplitude (not shown in the graph).
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While the M3 clearly remains increased after crossing the melting point, the MRX
relaxation time reaches a maximum at the melting point. This can be explained by the
presence of Brownian and Néel relaxation at the same time: TheMNP system exhibits a
broad distribution of Néel relaxation times that dominate the magnetic behavior up to
the melting point. A fraction of MNPs exhibits Néel relaxation times above the upper
limit of theMRXmeasurement timewindowwhat explains the small initial value of the
effective relaxation time. In the melting process, particles of those fraction now enter
the MRX measurement time window by the Brownian relaxation mechanism, which
leads to the maximum in the relaxation time. With increasing temperature, the MNPs
sense a strong change from high to low viscosity resulting in a decrease of their
viscosity-dependent Brownian relaxation times after the maximum. A more detailed
and quantitative interpretation can be found in Ref. [42]. The black squares in Figure 1
are the relaxation times obtained froma ferrogel thatwas hardened by electron beamof
strength 5 kGy. While no macroscopic melting was observed, small variations in the
relaxation times during the temperate increase are again attributed to changes in the
local viscosity.
Thus, we demonstrated that MRX and MPS are sensitive to both, the local and
macroscopic melting behavior of ferrogels.
3.2 Probing the spatial arrangement of MNPs within a matrix by
Néel relaxation
The Néel relaxation is defined as the thermal activated jump of the MNP magnetic
moment over the barrier of its anisotropy energy, i.e. the internal flip of the magneti-
zation vector. If MNPs aggregate, then dipole–dipole interactions betweenMNPsmight
Figure 1: MPS third harmonic M3 (open blue circles) and MRX relaxation time (closed blue symbols)
during melting of gelatin with embedded MNPs. Black curve: Relaxation time after hardening of the
ferrogel by electron irradiationwith 5 kGy dose protecting the gelatin frommelting up to at least 70 °C.
Adapted with permission from Wisotzki et al. [42]. Copyright 2017 Royal Society of Chemistry.
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alter these internal energy barriers. This affects themagnetic susceptibility detected by
ACS and MPS. Hence, changes in ACS or MPS signals provides information about the
aggregation state of embedded MNP probes. To investigate these changes, we immo-
bilized magnetite based MNP with a coating containing carboxylate groups on its
surface [42] in two different matrices, polyacrylamide (PAam) and gelatin. The MNPs
were added prior to the polymerization process to ensure their homogeneous distri-
bution within the sample. After polymerization, the samples were measured by MPS.
The observed spectra are depicted in Figure 2. The spectrum of the gelatin-based
sample decays much faster and the third harmonicM3 is only 31% of that of the PAam
based sample.
Using the parametersmagneticmoment distribution andminimal possible particle
distance, wemodeled theMPS spectra of immobileMNPs solving the Landau–Lifshitz–
Gilbert (LLG) equation considering the dipole–dipole interactions between the MNPs
(in collaboration with P. Ilg, University of Reading). We modeled the magnetization
response of close packed clusters comprising 30 randomly arranged MNPs of one size,
all having amean volume diameter of 19.4 nm. A clear dependence of themodeledMPS
spectra on the interaction parameter λd = μ0  μ2/(4πr3  kB  T) is found (Figure 2). The
interaction parameter λd describes the dipole–dipole interaction between two mag-
netic moments μ at a distance r. While the model of noninteracting MNPs λd = 0 de-
scribes the data of the PAam sample, an interaction parameter λd = 6.6 nm is necessary
for a description of the gelatin-based sample. This interaction parameter corresponds
to the interaction energy of closely packed MNPs. Hence, we conclude that the MNPs
are aggregated within the gelatin matrix.
Figure 2: MPS-data of ferro-hydrogels on the base of polyacrylamide gel (PAam) and gelatin
(symbols) together with the results of the LLG-model for clusters of 30 randomly arranged
immobilized MNP of one size (dm = 19.4 nm) taking into account the indicated interaction energies.
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We hypothesize that the observed aggregation is caused by negatively charged
carboxylate groups of the MNPs interacting with the charged collagenmolecules of the
gelatin. While gelatin A is predominantly positively charged (pI = 8.5–9) PAam does
not contain charged functional groups. Note, due to hydrolysis there may be a mo-
lecular content of carboxylate groups of about 2–6%.
3.3 Requirements on MNPs to probe particle–matrix interactions
3.3.1 Suppressing Néel relaxation to sensitively monitor the MNP rotation inside a
matrix
The physical state of the matrix (e.g., soft, hard, charged) can be characterized by
measuring the Brownianmotion of embeddedMNPs. Methods like ACS, MRX, andMPS
are very sensitive to detect rotational MNP movement while a translational motion
requires magnetic gradient fields to drag the MNPs through the matrix. To accurately
measure the rotational motion of the MNP as a whole, the Néel relaxation process (i.e.
the rotation of the magnetic moment within the MNP) should be suppressed by a
sufficiently high anisotropy energy barrier, i.e. τN >> τB. Cobalt ferrite is an appropriate
core material for such MNPs because its anisotropy constant is about 10 times higher
than that of magnetite. Furthermore, translational motion requires a high saturation
magnetization of the whole core–shell MNP and the overall size of the MNP should
match the structure size (pore size) under study. Finally, the analysis of dipolar in-
teractions (Section 3.2) requires MNPs with high magnetic moments and a thin coating
layer.
Figure 3: MPSphase data of the cobalt ferrite systemsC1*S andC2*COO− in comparison tomagnetite
basedmagnetosome particles LMU3 [43] dispersed in water and after freeze drying within amannitol
matrix.
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The prevalence of the dominating relaxationmechanism (Brownian orNéel) can be
assessed by the phase φ of the MPS data. For MNP systems with dominating Néel
relaxation it is often observed that the MPS phase smoothly decays with the number of
harmonics k asymptotically approaching to −180° (Figure 3). Such a characteristic
phase curve is shown for mobile and immobilized magnetite based magnetosome
particles LMU3 [43] in Figure 3. On the other hand, the Néel relaxation of cobalt ferrite
MNPs with a core diameter larger than about 12 nm is strongly suppressed. Therefore,
the Brownian relaxation dominates. TheMPS phase curve of theseMNPs decline nearly
linearly and much faster with phases far below −180° for higher harmonics. The phase
saturates at harmonic numbers, since here the signal of Néel relaxation of small MNPs
prevails that of Brownian relaxation.
3.3.2 Opsonization as consequence of MNP-biomolecule interactions
The coating of MNPs influences their functionality and clearance in biomedical
applications. The properties of the coating (thickness, density) might further be
influenced by the medium in which the MNPs are dispersed. A prominent example is
the opsonization of MNPs by proteins that may occur in blood and determines the
interaction of the MNPs with the organism. Here, we combined the information gained
by themagneticmeasurementmethodACS and Small AngleNeutron Scattering (SANS)
to probe the opsonization of MNPs by the thickness and density of their opsonization
layer. The thickness of the MNP coating can be estimated from the difference between
hydrodynamic diameter dh and core diameter dc. MRX and ACS are promising integral
measurementmethods for the estimation of the distribution of dh [44, 45]. The complex
susceptibility χ(ω) asmeasured byACS iswell suited to estimatedh.Wemodeled χ(ω) of
noninteracting MNP with a lognormal core diameter distribution, f(dc), assuming each





1 − iωτeff dc (12)
Here, Ms denotes the saturation magnetization and L the Langevin function. The hy-
drodynamic volume is given by Vh = π(dc + δs)3/6. This becomes of particular interest
when measuring in a (biological) environment. We estimated the thickness of the
MNP’s shell, δs, fitting the model of Equation (12) to χ(ω).
Small Angle Neutron Scattering (SANS) with contrast variation provides a very
sensitive access to the thickness of theMNP coating [46–48]. The scattering intensity of
the sample scales with the square of the difference of scattering length densities of the
particle core, ρp, the particle’s shell, ρs, and that of the whole sample, ρ0. Here, we
varied ρ0 by replacing H2O by heavy water D2O. In H2O the contrast is mainly deter-
mined by the nanoparticle core scattering and in D2O the details of shell structure are
seen (see, e.g., [49]). The SANSmeasurement were performed on the instrument KWS-1
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[50, 51] at the MLZ in Garching, Germany. The incident neutron wavelength λ was 7 Å
(Δλ/λ = 10%). Data was obtained from two different detector and collimation distances:
the detector distances of 1.5 and 8m and a collimation distance of 8m leading to a total
Q range of 0.05–1.5 nm−1. The samples weremeasured in quartz cells with beampath of
1 mm for H2O and 2 mm for D2O. The measurements were done at room temperature.
The size of the sample aperture was set as 6 × 6 mm. The data presented here were
converted to an absolute intensity unit ofm−1 taking into account the sample thickness,
transmission, the scattering from a standard sample and the background from elec-
tronic noise, the solvent and the quartz cell. Data reduction has been done using the
QtiKWS software [52].
Fitting a model [53, 54] describing the SANS data by noncorrelated core–shell
particles (Figure 4) with the corresponding scattering length densities, we could esti-
mate the thickness δs and densityϕs of the polymeric shell of theMNP systemM1*COO
−
to δs = 2.9(1)nm and ϕs = 1.0(2). Note, that only particles with a very narrow size
distribution make the analysis robust (Figure 4b).
The particles M1*COO− were dispersed in a 4.3% bovine serum albumin (BSA)
solution to probe their opsonization, i.e. a corona formation of BSA around the MNPs
increasing their hydrodynamic diameter. For the estimation of the thickness of the
second layer, i.e. the opsonization layer, we combined SANS and ACS data using a
common model where both submodels share the same fit parameters of the particle
Figure 4: ACS-data (left) and SANS-data (right) of the commercially available nearly monodisperse
MNP system SHP-30, denoted as M1*COO−, before (blue symbols) and after opsonization by BSA (red
symbols). The chosen for ACS delineation already eliminates the effect of the sample viscosity η on
the data. The lines represent the best fit of a model of lognormally distributedmagnetite cores with a
coating and a corona layer of one thickness (inset). The short dash line represents the best fit model
with coronawith an adjusted density volume fraction of the corona,ϕcor, illustrating the sensitivity of
SANSwith respect toϕcor. The SANS data of the sample with the opsonizedMNP (in BSA) suffers from
a quite large systematic uncertainty because of the high intensity of the background scattering of the
BSA-solution. A solvation layer thickness of 1.5 nmwas assumed in the fit.ϕ and η denote the volume
fraction of core material, here magnetite, and the viscosity of the sample, respectively.
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structure (Figure 4). This was reasoned because of the relatively weak signal change in
SANS by the opsonization and a relatively large uncertainty in SANS due to the large
background signal. The fit yields an opsonization layer thickness of δcor = 3.3(3)nm
(Table 1). This matches well with the shortest dimension of an BSA molecule the
shape of which is assumed similar to an oblate ellipsoidal shape with axes of
(3.4 × 8.4 × 8.4) nm3 [54].
The relatively small signal increase measured following the opsonization
(Figure 4b) reflects the low density (or volume fraction) of the corona formed by
opsonization of about ϕcor = 0.1. Note that ϕcor was adjusted manually because of
fitting instabilities caused by the relatively large systematic uncertainties asmentioned
above. Also, the applied core-shell-opsonization layermodel (Figure 4b inset)might be
an oversimplification of the real corona structure. For instance, the corona might have
an inhomogeneous structure as suggested in [55]. The resulting lower fractal dimen-
sionality would explain the slightly slower decay of I(q) of opsonized MNPs within the
Porod regime, as marked by dashed line. It was shown that ACS reliably allows to
estimate the thickness of an opsonization layer while SANS additionally yields the
density of this layer. By combined evaluation of ACS and SANS data, we could enhance
the confidence of the results. In particular, with given thickness of the solvation layer,
ACS sensitively displays the increase of the hydrodynamic diameter of theMNPs by the
opsonization process.
3.4 Translational motion of MNPs with different coatings in
matrices
To gain information about the migration of MNPs within a biological matrix, we
investigate the translational motion of MNPs driven by an external magnetic field
gradient through a collagen matrix. To achieve a large magnetic force, we utilized
MNPs with a large magnetic moment of about 4 aAm2. The MNPs were similar to those
used in Ref. [42]. As mentioned above, the capability of the outer MNP shell to bind to
the matrix determines the MNP’s functionality. Therefore, we used two MNP systems
with identical cores but different coatings. The carboxymethyl dextran shell of the first
Table : Mean volume core diameter, dcv, thickness of the coating shell, δs, and the thickness of the
corona, δcor, obtained by fitting analysis of ACS, M(H), and additionally for M*COO−, SANS data.
Quantity M*COO− M*COO−
dcv/nm . ± . . ± .
δs/nm . ± . . ± .
δcor/nm . ± . . ± .
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system, M2*COO−, presents carboxylate groups leading to a negative zeta potential at
neutral pH. The second system, M2*CONH-PEG (Table 2), was prepared by coupling
amino-PEG to M2*COO−. Theoretically, no charged functional groups are present in
M2*CONH-PEG. This leads to the hypothesis that M2*CONH-PEG can be moved more
effective by a field gradient through a hydrogel thanM2*COO−. To verify this, we filled a
tubular sample holder with collagen gel and loaded it with MNP dispersions. A ho-
mogeneous magnetic field gradient of 8 T/m was applied for 48 h. Afterward, the
sample holderwith the collagenwas dissected into nine segments and theMNP content
of each collagen segments was quantified by MPS. The results show that the concen-
tration of M2*CONH-PEGwithin the second segment is 2.4 times higher than that of the
Figure 5: Left: Experimental set-up for the drag of MNP through a collagen gel by a magnet field
gradient. Right: Concentration of MNP (iron) within each collagen segment (of nine) quantified by
MPS.
Table : Mean volume core diameter, dcv, thickness of the coating shell, δs, and the thickness of the
corona, δcor, obtained by fitting analysis of ACS and M(H) data.
Quantity M*CONH-PEG
dcv/nm . ± .
δs/nm . ± .
δcor/nm . ± .
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corresponding M2*COO− sample (Figure 5). Hence, M2*CONH-PEG has a substantial
higher mobility in collagen than M2*COO−.
Then, we related the observed different mobility in a collagen gel to the opso-
nization by BSA, justified by the molecular similarity of collagen and BSA. We
checked the ability of the MNP to bind the proteins BSA by opsonization mea-
surements using ACS as it was done in Section 3.3.2, for M1*COO−. The fit of
Equation (12) to the ACS data of samples prior to BSA incubation (Figure 6) reveals
that the coating of M2*CONH-PEG is about 18 nm thicker than in M2*COO− (Table 1).
Obviously, this is the PEG-layer thickness. After BSA incubation the hydrodynamic
size of M2*COO− increases by 4.2 nm while it does not change for M2*CONH-PEG
(Tables 1 and 2). M2*CONH-PEG was also not opsonized, even by fetal calf serum
(FCS) albumin which contains, in contrast to BSA, a rich variety of proteins and
othermolecules. This observation supports the commonly accepted thesis of stealth
properties of PEG decorated particles [56].
The apparent absence of any opsonization of M2*CONH-PEG correlates well with
the observed higher mobility through the collagen gel as shown above. Furthermore,
we expected thatM2*CONH-PEGwould have passed through the all gel segments of the
tubular sample holder after 48 h since the largemean pore size of about 100–200 nmof
the collagen gel, inferred from reference [57] where a PAam gel of nearly the same
composition was investigated by TEM. Hence, it seems to be likely that the
M2*CONH-PEG mobility is reduced by binding to the collagen matrix.
Figure 6: ACS-data of the magnetite MNP systems M2*COO− (a) and M2*CONH*PEG (b) before and
after opsonization with BSA and FCS. The data were normalized to the volume fraction of magnetite,
ϕ. A model of noninteracting core–shell MNP was fitted simultaneously to M(H) and ACS-data (lines).
The dashed line on the right axes in (b) represents the curve of M2*COO− before opsonization, with
adapted amplitude for better comparison.
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4 Multicolor magnetorelaxometry imaging for
quantitative visualization of particle–matrix
interactions
4.1 Classical MRXI and multicolor magnetorelaxometry imaging
Classical MRXI focuses on the quantitative reconstruction of a spatial MNP distribu-
tion. Because the relaxation curve is very sensitive to the direct environment of MNPs,
MRXI has been extended to also gain information about interactions between MNPs
and their surrounding matrix [58, 59]. By this approach, called multicolor MRXI, the
spatial distribution of MNPs interacting with different molecular environments (e.g.,
liquid, blood, cells, tissue matrix) or MNPs with distinct properties (e.g., size distri-
butions) can be reconstructed and separated. For convenience, we further summarize
such differences as phases. As an example, Figure 7 shows classical MRX imaging and
the multicolor MRXI approach on two distinct MNP distributions, with the respective
MRXI reconstructions in the insets.
Our MRXI setup consists of an MNP distribution phantom, a set of excitation coils
on printed circuit boardsmounted on top (not shown in Figure 7 for clarity) and bottom
of the phantom and a 304 SQUID sensor system [60] for MNP relaxation detection. The
Figure 7: MRX imaging usingmultiplemeasurements on a rabbit phantom. TheMNPphantommodels
defined MNP distributions with physical and physiological parameters of magnetic drug targeting
application in rabbits. Left support: MNP test distribution in the tumor region of the rabbit phantom
(brown cubes containing 6 mg of MNP each) and reconstructed MNP distribution after MRX imaging.
Right support:multicolorMRXI withMNP support containing 1mLMNP suspension (12mgMNP) and 9
MNP loaded gypsum cubes (brown cubes containing 6 mg of MNP each) and MRXI reconstructions
achieved by multicolor MRXI for MNPs in liquid phase (blue-green voxels) and MNPs solid phase
(brown voxels).
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phantomhas a shape and size comparable to a rabbit andwas developed to analyze the
performance of MRXI in amagnetic drug targeting study done by Alexiou et al. [61, 62].
The phantom contains two supports, to model the regions-of-interest (ROIs) in the
tumor region (left) and the liver region (right) of the rabbit. Each support allows
the flexible arrangement of MNP distributions within a total volume of
9.6 cm × 9.6 cm × 6 cm. The circuit boards provide 15 excitation coils above and below
each support. The coils are applied sequentially to generate the spatially constrained
magnetic fields of the MRXI sequence.
For classical MRXI (which assumes all MNPs in the same phase), we formed in the
ROI tumor an MNP distribution resembling the letter “P” out of 15 gypsum cubes (each
loaded with 3.7 mg/cm3 MNPs). Here, all MNPs are in a solid phase, i.e. fixed in a
gypsum matrix, so that only Néel relaxation contributes. The MRXI reconstruction
reveals a high correlation to the nominal MNP distribution (Pearson’s correlation co-
efficient >95%) and a mass deviation of the phantom’s total MNP amount below 10%
[58].
In the multicolor MRXI experiment, we used an MNP distribution containing two
phases (MNPs in a solid matrix and MNPs suspended in a liquid) arranged in the ROI
liver (right support and inset of Figure 7). The MNP distribution in the solid phase is
formedof nine gypsumcubes (each loadedwith 3.7mg/cm3MNPs) resembling a square
and placed beside a 1 mL MNP suspension in a liquid phase (12 mg/cm3 of MNPs) in a
circular container of 2 cm diameter. For the chosen MNP relaxation type we mainly
have Néel relaxation in the region of MNPs in the solid phase and Brownian relaxation
in the region of MNPs in the liquid phase. This allows for a quantitative separation of
MNPs in both phases in oneMRXImeasurement as visualized by different colormaps in
Figure 7 (the brown color corresponds to the MNPs in solid phase and the blue color to
the MNPs in the liquid phase). Applying multicolor MRXI, it was possible to simulta-
neously and quantitatively reconstruct and separate MNPs in both phases forming our
MNPdistributionwith a totalmass deviation below 10% [58]. In the following,wedetail
ourmulticolorMRXI approach and extend the phantoms from this two-phase system to
multiphase systems [59].
4.2 Extending MRXI to quantitatively imaging particle–matrix
interactions
While classical MRXI employs only the amplitude κ(t1, t2) for image reconstruction, we
make use of the complete relaxation curve shape κ(t) in our multicolor MRXI approach
[59]. This additional temporal information allows to extract portions of distinct MNP
relaxation curves due to different phases out of a single MRX measurement. In our
approach, the MRXI reconstruction is split up into two subproblems as schematically
depicted in Figure 8. The first subproblem finds the relative contributions of N distinct
MNP relaxation curves χnκn(t) (N distinct phases) to themeasured signal in the sensors.
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These are obtained from reference measurements of samples in a specific phase under
well-known and controlled conditions. It is assumed that similar phases occur
simultaneously in the sample under investigation. The second subproblem finds the
associated MNP distribution to the previously determined relative contribution in the
sensors. These N distributions are finally merged in a color-coded image in which the
color represents the specific phase and the intensity reflects the amount ofMNPs. In the
reference measurement well-known MNP samples with controlled phase are posi-
tioned at location rv and the MRX signal is normalized to appliedmagnetic fieldHv and




4π(3(nTs (rs−rv))(rs−rv)T))‖(rs−rv)‖5 − nTs‖(rs−rv)‖3
)Hv  Xref, n  . (13)
Figure 8: Principle of multicolor MRXI. An actual MNP distribution (top) containsN = 4 compartments
where the MNPs are either suspended (blue), dispersed in blood (red), in cells (green) or bound to a
fixed matrix (yellow). In a first subproblem, each measured relaxation signal Bmeas, i(t) of the MRXI
sequence is decomposed into portions of four reference MNP relaxations αnκn( t), recorded on MNP
samples of known MNP mass and in the respective environment. By this, a coefficient matrix α∗ of
dimension (KS × N) is obtained, containing the contributions of each MNP relaxation type row-wise.
In the second subproblem, an inverse problem X∗n= argmin‖(L(χn,  κn( t1, t2))Xn) − α∗n‖ is solved
independently for eachMNP relaxation type and the result X∗n assigned to a different color. Finally, an
overlay of all X∗n is created to generate the multicolor MRX image.
18 M. Liebl et al.
The measured relaxation in the experiment Bmeas(t) is then modeled as a linear com-
bination of theN reference relaxations αn  κn( t). Consequently, the first subproblem can





αn  κn(t)) − Bmeas(t)‖ (14)
to split-up Bmeas(t) into the contributions of the different phases. This problem is
solved using NNLS (Equation 7) assuming the absolute contributions to be positive
values, which is a correct approximation after signal filtering. Thus, α∗ (dimension
1 ×N) contains the relative contributions of theN phases in a singleMRXmeasurement.
Applying Equation (14) to the complete MRXI data set, i.e. K MRX measurements of S
sensors, yields the final coefficient matrix α∗ of dimension (KS × N).
The solution of this first subproblem in the example in Figure 8 separates the signal
into N = 4 phases originating from MNPs in suspension, in blood, in cells and immo-
bilized in a tissue matrix, respectively. Therefore, we first prepare MNP reference
samples of knownMNPmassXref that emulate best the respective phase. Two reference
MNP samples are simply suspendedMNPs and immobilizedMNPs, e.g., freeze-dried in
a sugar matrix. The other two samples are prepared by diluting the MNP suspension in
whole blood and the cell type of interest. These (small) samples are then consecutively
measured by MRX to parameterize our data model (Equation 13) with χnκn(t). The four
rows of the coefficient matrix α∗ obtained by Equation (14) contain the signal contri-
butions of each phase for all MRX measurements of the MRXI sequence. Note that the
signal separation can be advanced by the choice of appropriate time windows to
evaluate each κn(t) based on the reference properties (e.g., using only time frameswhen
the signal-to-noise ratio of κn(t) is above a certain limit) [59].
With this coefficient matrix, we enter the second subproblemwhich is the imaging
problem. Here, Equation (7) is solved independently for each phase:
X∗n = argminXn ‖ (L(χn, κn(t1,  t2))Xn) − α
∗
n‖,   n = 1,…,  N (15)
Since the time-dependence κ(t) was already employed in the first subproblem for signal
separation, it is sufficient to use the amplitude difference of κn(t1, t2) in the imaging
problem. As a result, we obtain independent 3D MRXI reconstructions X∗n for each
phase n. The overlay of all N fractional MNP distributions X∗n is the reconstructed MNP
distribution obtained by multicolor MRXI. In our example in Figure 8, the second
subproblem is solved independently for each row of α∗ = [α∗1 ,α∗2 ,α∗3 ,α∗4] to obtain four
individual quantitative MNP reconstructions that belong to each phase of the MNP
distribution. The final multicolor MRXI image is then the overlay of the four MNP
distributions encoded by color to show the phase.
In Figure 9,we experimentally demonstratemulticolorMRXI on aMNPdistribution
measured in the ROI tumor of the rabbit-sized phantom [59]. The MNP distribution was
assembled of MNPs in N = 4 phases as listed in Table 3, while Figure 9 shows a
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photograph of the MNP support (a), the nominal MNP distribution (b), the resulting
four fractional MRXI reconstructions (c) and their overlay (d). Note that except for the
freeze-dried sample of F200 in which the particles were embedded in a solid phase, all
MNPs were suspended in a liquid in our experiment. Hence, we mainly varied the MNP
size distributions to generate distinct phases to emulate different PMIs. These systems
allow us to investigate multicolor MRXI under well-defined experimental conditions.
The MNP systems applied are fluid MAG-D (chemicell GmbH, Germany) and
nanoMAG-D (micromod Partikeltechnologie GmbH, Germany).
The MNPs in the four phases are only placed one voxel (1.2 cm) from each other. In
this case, the complexity of both multicolor MRXI subproblems increases compared to
the previous MNP distribution (Figure 7) in which only MNPs in two spatially well-
Figure 9: MulticolorMRX imaging of theMNPdistribution assembled in theMNP support ROI tumor in
the rabbit-sized phantom. (a) Photograph of the MNP support showing the spatial arrangement of
MNPs in four different phases within their respective sample container (V = 0.5 mL). (b) The nominal
MNP distribution for the four MNPs phases with 200 nm MNPs (F200: green), 300 nm MNPs (F300:
orange), 200 nm freeze-driedMNPs (F200 fd: blue) and 500 nmMNPs (F500: violet). Each sample fills
a single voxel in the reconstruction grid of 10 × 10 voxel with a spatial resolution of 1.2 cm,
respectively. The four single-color reconstructions X∗n are shown in (c) and their overlay is shown in
(d). A high degree of similarity to the nominal MNP distribution is visible. Adapted with permission
from Coene et al. [57]. Copyright 2017 IOP Publishing.
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separated phases are present. The multicolor MRXI reconstructions, however, show
excellent correspondence to the nominalMNPdistribution.MNPs in the four phases are
spatially well separated in the image that shows a correlation above 87% for all MNP
distributionsX∗n and even 96% for F200. Even in imaging this four-phase MNP system,
multicolor MRXI accomplishes a quantitative reconstruction with a total mass devia-
tion below 30%.
This clearly demonstrates the ability of multicolor MRXI to quantitatively image
PMIs. MNP distributions containing MNPs in up to four different phases were quanti-
tatively resolved with a sensitivity in the milligram/cubic centimeter range.
5 Flow induced particle–matrix interactions
5.1 Microscale visualization of particle–matrix interactions in flow
In this section, we investigate interactions between particles and flowing media. By
magnetic monitoring of these interactions, we aim to employ the particles as local flow
probes. On the one hand, this is important for biomedical MNP applications, where
particle interactions with the circulatory system influence the efficiency of biomedical
applications. On the other hand, this might enable the detection of perturbations in
the hemodynamics, as, e.g., attributed to pathologic narrowing of vessels
(atherosclerosis).
Inside the circulatory system, MNPs experience Stokes friction and shear forces
generated by the blood flow. These forces result in translational and rotational MNP
motion. In medical imaging (e.g., [63, 64]), translational MNP motion is visualized by
mapping the transit of a contrast agent MNP bolus moving with the blood stream.
However, the dispersion of MNPs in blood hardens blood flow quantification based on
this motion. At the same time, rotational MNP motion that might give additional in-
formation on the hemodynamics is not visible.
Here,we detail a novelmethod calledmagneticmicrosphere tracking (MMT) [65]. It
might overcome these limitations by magnetic monitoring of translational and rota-
tional particlemotion. A single permanentmagneticmicrosphere (MM)with a diameter
Table : MNP properties under study.
Name Type Size (nm) Amount (mg Fe)
F FluidMAG-D  
F freeze-dried FluidMAG-D  
F FluidMAG-D  .
N NanoMAG-D  .
Magnetic measurement methods 21
of a few micrometer locally probes the flow while passing through a vessel. The 304
SQUID sensor system [60] detects these movements and allows for high-resolution
(millisecond/millimeter) 3D tracking of the translational and rotational motion of the
sphere’s magnetic moment in a field-of-view (FOV) of 15 × 20 cm. By this, we suc-
cessfully localize and evaluate diameter constrictions in an arteria phantom. The size
of the applied MM (d = 34.6 µm) is close to that of red blood cells (6–8 µm) and
demonstrates the potential for biomedical MMT application for blood flow
quantification.
The concept of MMT is sketched in Figure 10. Here, aMMwith permanentmagnetic
moment moves inside a vessel due to the hydrodynamic forces applied by the flow
profile. The diameter of the vessel decreases along the x-coordinate due to increasing
grades of stenosis. Thus, the flow vectors of the quadratic flow profile increase along x.
A shear force acts on the MMdue to variations of the flow vectors over the cross-section
of the sphere. This force induces a rotational motion to the MM while drag forces
translate it. Hence, the angle δ between MM magnetic moment and x-axis oscillates
along x at a certain frequency determined by the shear force. Thus, the rotational
frequency of these oscillations increases with narrowing vessel diameter due to
increasing shear forces. At the same time, themotions of theMMmagnetic moment are
remotely detected by a SQUID sensor at location rs above the vessel. The amplitude of
the SQUID signal depends on the actual position of the MM rv(t) = [rx(t), ry(t), rz(t)]
relative to the SQUID. The distance dependency
Bs(t) = μ04π (
3(nT(rs − rv(t))(rs − rv(t))T)
‖(rs − rv(t))‖5 −
nTs
‖(rs − rv(t))‖3)m(t) (16)
is employed to localize the actual position rv(t) and magnetic moment m(t) = [mx(t),
my(t),mz(t)] of theMMby the SQUID array iteratively for each discretemeasured sample
t = [T1, …, Tend]. This can be accomplished by solving the inverse problem
Ω(rv(t),  m(t)) = argmin
Ω
‖ [B1(t),…,  BS(t)]T − Bmeas(t)‖,   t = T1,…,  Tend. (17)
using a Levenberg–Marquart optimizer [66, 67] to iteratively minimize the
functionalΩ(rv( t),  m( t)) by parameter variation rv(t) and m(t). The inverse problem
was simplified by the constant MM magnetic moment of |m| = 10 nAm2 that allows to
reduce themodel parameters to threeMM coordinates in 3D space and the two angles α
and β defining the orientation of itsmagneticmoment, i.e. five degrees of freedom. This
dipole localization was applied for each measured sample recorded during the MM
passage through a flow phantom with a sampling frequency of 750 Hz, i.e. a temporal
resolution of round 1.3 ms. We calculated the translational MM movement as first
derivate of r′v(t) over time and estimated theMM rotational frequency by the oscillations
of the angles α and β. For further details see [65].
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5.2 Tracking a single magnetic microsphere to monitor the fluid
dynamics
Here,we applyMMT to visualize PMIs in the flowphantomdepicted in Figure 11a [65]. It
consists of a straight tube section with a constriction region of 1 cm length. Here,
variable diameter reductions dr of the original tube diameter (dtube = 1.5 mm) of up to
50% can be adjusted. An additional curved tube section provides a secondary flow
(Dean effect [68]) resulting in lateral migrations of the MM whether toward the tube
center or wall. Note that these migrations would either lead to an increase in velocity
and decrease in rotational frequency when the MM migrates toward the centerline or
vice-versa. A constriction, however, results in a temporary increase in both, MM ve-
locity and rotational frequency. The MM was separated from commercial Magne-
quench® powder (MQP™-S-11-9) using a cell selector (ALS®) and magnetized at a flux
density of 5 T. The flowmedia was pumped by a syringe pump (Landgraf®, LA800) at a
constant flow rate of 30 mL/min (Re = 212).
The localized x- and y-positions obtained by MMT are depicted in Figure 11b. The
path of the MM is encoded by color to show the rotational MM frequency frot. For an
Figure 10: Principle of magnetic microsphere tracking: a microsphere with permanent magnetic
moment passes an artery with increasing diameter constrictions (grades of stenosis) and thus,
increasing velocity vectors of the quadratic flow profile. Due to the shear forces, the angle delta
betweenmagneticmoment and x-axis will oscillate along xwith increasing frequency. This oscillation
is then detected by a SQUID and the actual sphere position tracked by a sensor array. Reproduced
from Ref. [63] under the Creative Commons Attribution 4.0 International License.
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adjusted diameter constriction of dr = 50%, a clear increase of the rotational frequency
is visible when the MM passes the constriction region and it remains constant in the
absence of a constriction. The enlargements in Figure 11b showMMpath and rotational
frequency through the constriction region for variable diameter constrictions. A
decrease of the rotational frequency is observed with increasing cross-section of
the tube.
As expected, a decrease of the rotational frequency is also visible in the curved tube
section when the MM migrates toward the tube center due to the applied secondary
flow.
Figure 11c shows an enlarged view of the localizedMMpositions (y–zplane) during
the passage through the constriction region for different diameter reductions. The color
of the MM path is encoded by color to show the local velocity v. An abrupt acceleration
is visible when the MM enters the constriction, and it decelerates again when it has left
the constriction. Inside the constriction region, theMMvelocity increase systematically
Figure 11: Magnetic Microsphere Tracking in a flow phantom. (A) The flow phantom comprising a
straight and a curved tube section. In the straight section variable constrictions can be applied over a
length of 1 cm using four nylon screws. (B) Localized x, y – position of theMM color coded to show the
rotationalMM frequency. The insets show an enlargement of the constriction region. A systematically
increasing rotational MM frequency with increasing diameter reduction dr is visible. (C) Enlargement
of the localized y, z – positions of theMM in the constriction region for different diameter reductions.
TheMM trace is color coded to show theMMvelocity. A clear acceleration is seenwhen theMMenters
the constriction and it decelerates when it leaves the constriction. Reproduced from Ref. [63] under
the Creative Commons Attribution 4.0 International License.
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with decreasing tube diameter, while it remains unchanged in the absence of a
constriction. Hence, the degree of constriction has a clear impact on the MMT locali-
zation parameters frequency and velocity.
Hence, MMT allows to visualize microscale PMIs in flow by tracking a single
microsphere (size range of a red blood cell) with a temporal resolution of 1.3 ms and a
spatial resolution below 1 mm. From the measurements we were able to quantify the
flow conditions experienced by the microsphere. This enables localization and quan-
tification of constricted volumes and distinction from lateral MM migrations. Addi-
tionally, separating influences of Stokes friction and shear flow makes MMT an ideal
tool for rheology investigations andmight help to understand complex flow dynamics.
By its properties (quantitative, high resolution, no radiation, no tissue contributions,
low marker dose [ng]) MMT holds great potential for biomedical blood flow quantifi-
cation (more details in [65]).
5.3 Sensing of particle–matrix interactions in flow on the
nanoscale
In the following, we investigate flow-induced PMIs in the nanoscale usingMRX [69]. To
accomplish this, we combine our MRX device comprising of a SQUID detector and a
magnetizing coil with a flow phantom as sketched in Figure 12a. For flow experiments,
3 mL of a homogeneous MNP solution was injected into a 5 m long PVC tube with inner
diameter of 0.8 mm. Inside the magnetizing coil of the MRX device, i.e. the sensing
volume, the tube was arranged to form a coil with five turns. The field vectors of the
applied magnetic field were oriented perpendicular to the flow direction. The MNP
Figure 12: MRX measurements in flow. (a) Scheme of the experimental setup for the MRX
measurements of MNPs under flow conditions. Driven by a syringe pump, the MNPs are flowing
through the tube inside the MRX magnetizing coil of the MRX measurement device. To increase the
sample volume inside the magnetizing coil, the tube is coiled up on a nonmagnetic core with five
turns. The magnetizing coil is placed under the bottom of the SQUID sensor for detection of the
magnetic relaxation. On the right, relaxation amplitudes ΔB (b) and relaxation times t1/e (c) as
function of the flow rate Q are depicted. These were obtained for dilutions of the original MNP
suspension by a ratio of 1:10 (FM10), 1:100 (FM100), 1:1000 (FM1000) with BSA. Adapted with
permission from Slabu et al. [67]. Copyright 2017 IOP Publishing.
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suspension was pumped through the tubing system by a syringe pump (LA-120, New
Era Pump Systems, USA) at a constant flow rate. MRX measurements were performed
with constant flow rates adjusted between 0.6 up to 16mL/min.We used homogeneous
fluidMAG/12-HS/130 (chemicell GmbH, Germany) suspensions of iron concentration
c = (2.8, 0.28, 0.028 mg/mL), respectively. In the MRX magnetizing phase, an external
magneticfield of 2mTwas applied to theMNP suspension formagnetizing time of 1 s. In
the measurement phase, the resulting MRX signal was recorded by the SQUID sensor
for a measurement time of 0.5 s at a sampling frequency of 100 kHz.
The characteristicMRXparameters relaxation amplitudeΔB and relaxation time t1/e
are depicted in Figure 12b and c as a function of the flow rate Q, respectively. Inde-
pendent on MNP concentration, a clear decrease in both parameters with increasing
flow rate is visible. Hence, shear-stress induced rotational MNP motion fastens Brow-
nian relaxation and decreases the relaxation amplitude. Interestingly, while ΔB
decreases proportional to the applied flow rate, the decrease of t1/e nearly saturates for
flow rates above 8 mL/min. This effect is reproducibly visible in all three MNP con-
centrations. This saturation behavior indicates a change in the tube flow profile. Slight
concentration dependent variations, i.e. faster decreasing relaxation amplitudes and
relaxation times for the higher concentrated FM10 are visible as well. This might be due
to MNP provoked shear thinning and structure formation as, e.g., nanoparticle chain
formations [69].
To summarize, we sensitively detect flow-induced changes in the Brownian
relaxation of MNPs by MRX measurements. By analyzing the characteristic MRX pa-
rameters relaxation amplitude and relaxation time, we apply the MNPs as local probes
to quantify flow and determine perturbations in the flow profile.
6 Summary and conclusion
We reviewed magnetic measurement methods that sensitively detect particle–matrix
interactions and thereby, access the physical properties of the molecular MNP envi-
ronment. For selected MNP-matrix systems, we demonstrated that the combination of
different noninvasive and sensitive magnetic measurement techniques for specific
MNPdetection is a powerful approach to provide insights into dynamic processes of the
MNPs as, e.g., binding kinetics, cellular uptake, passage through cell barriers and heat
induction.
Furthermore, we developed functional imaging approaches that allow for spatially
resolved investigation of particle–matrix interactions. Here, we utilized the impact of
particle–matrix interactions on the MNP relaxation to advance MRX imaging with a
multicolor approach and to resolve the location, quantity and molecular environment
of MNPs. This technique might become a valuable tool to visualize and quantify par-
ticle–matrix interactions in preclinical research and propelling the development of
future particle mediated therapies.
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As MNPs in nearly all biomedical applications are subject to body fluids and their
prevailing fluid dynamics, we investigated flow-induced particle interactions. These
can be detected by sensitive magnetic measurement methods to quantify the fluid
dynamics acting on particles in the micro- and nanoscale. Magnetic microsphere
tracking allows for the spatially resolved quantification of the fluid dynamics based on
the particle velocity and rotational frequency with excellent temporal and spatial
resolution. This novel method has great potential to become a valuable tool for
rheology or even biomedical blood flow quantification and to pave theway for a deeper
understanding of flow-induced particle dynamics inside the body.
Though countless MNP systems with sizes in the nanometer andmicrometer range
have beendeveloped and applied for biomedical applications in recent years, there still
is strong demand for further MNP research. To facilitate this, an accompanying
development and improvement of established measurement techniques and analysis
methods for MNPs and their interaction with biological environment is a mandatory
prerequisite.
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